Online citations, reference lists, and bibliographies.

MiR‐134 Inhibits Non‐small Cell Lung Cancer Growth By Targeting The Epidermal Growth Factor Receptor

Qin Qin, Furong Wei, Jianbo Zhang, Xingwu Wang, Baosheng Li
Published 2016 · Medicine, Biology
Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract The epidermal growth factor receptor (EGFR) is frequently activated in a wide range of solid tumours and represents an important therapeutic target. MicroRNAs (miRNAs) have recently been recognized as a rational and potential modality for anti‐EGFR therapies. However, more EGFR‐targeting miRNAs need to be explored. In this study, we identified a novel EGFR‐targeting miRNA, miRNA‐134 (miR‐134), in non‐small‐cell lung cancer (NSCLC) cell lines. Luciferase assays confirmed that EGFR is a direct target of miR‐134. In addition, the overexpression of miR‐134 inhibited EGFR‐related signaling and suppressed NSCLC cells proliferation by inducing cell cycle arrest and/or apoptosis, suggesting that miR‐134 functions as a tumour suppressor in NSCLC. Further mechanistic investigation including RNAi and rescue experiments suggested that the down‐regulation of EGFR by miR‐134 partially contributes to the antiproliferative role of miR‐134. Last, in vivo experiments demonstrated that miR‐134 suppressed tumour growth of A549 xenograft in nude mice. Taken together, our findings suggest that miR‐134 inhibits non‐small cell lung cancer growth by targeting the EGFR.
This paper references
Cancer treatment and survivorship
R Siegel (2012)
10.1186/1756-9966-33-50
Multiple functions of hypoxia-regulated miR-210 in cancer
Qin Qin (2014)
10.1089/dna.2014.2629
miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Yiyang Liu (2015)
10.1038/nrclinonc.2014.104
Acquired resistance to TKIs in solid tumours: learning from lung cancer
David Ross Camidge (2014)
Micro- RNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma
Lk Wang (2014)
10.1007/BF01213008
About the authors
Per Capita (2005)
10.1038/nrm3838
Regulation of microRNA biogenesis
Minju Ha (2014)
10.1038/nm.3388
The quest to overcome resistance to EGFR-targeted therapies in cancer
C. R. Chong (2013)
10.1371/journal.pone.0096718
MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer
Xingchen Zhou (2014)
10.1371/journal.pone.0087665
Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin β1 in Hepatocellular Carcinoma
Ruopeng Zha (2014)
10.1016/j.bbamcr.2013.10.003
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells.
David M. Poitz (2013)
Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta1 in hepatocellular carcinoma
R Zha (2014)
10.1111/jcmm.12136
Journal of Cellular and Molecular Medicine
Won Jin Cho (2014)
Cancer treatment and survivorship statistics
R Siegel (2012)
10.3892/ijo.2013.1844
MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression
Chao-Shi Niu (2013)
10.1038/nrc3932
MicroRNA biogenesis pathways in cancer
Shuibin Lin (2015)
10.6004/JNCCN.2015.0071
Non-Small Cell Lung Cancer, Version 6.2015.
D. Ettinger (2015)
10.1038/cdd.2013.196
Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma
Y. Zhang (2014)
10.1016/j.yexcr.2014.10.022
The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Yan Chen (2015)
10.1038/nature04367
A brain-specific microRNA regulates dendritic spine development
G. Schratt (2006)
Biochim Biophys Acta
(2013)
10.1056/NEJMra0707704
EGFR antagonists in cancer treatment.
F. Ciardiello (2008)
10.1038/nrc3166
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Andrea L. Kasinski (2011)
10.1038/nature03702
MicroRNA expression profiles classify human cancers
J. Lu (2005)
10.1016/j.febslet.2012.09.016
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Jipeng Li (2012)
ulation of epidermal growth factor receptor signaling in human cancer cells by microRNA7
T Chiyomaru (2009)
Micro- RNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Y Tay (2008)
10.1158/0008-5472.CAN-10-0638
EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Y. Chou (2010)
10.1074/jbc.M804280200
Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7*
Rebecca J. Webster (2009)
Non-small cell lung cancer, version 6
D S Ettinger (2015)
10.1159/000434741
MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer
Qiang Zhen (2015)
10.1002/ijc.28358
miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
Chung-Ji Liu (2014)
10.1016/j.radonc.2011.05.050
microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.
Kyung Min Lee (2011)
10.3892/ijo.2014.2752
Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer
Takeshi Chiyomaru (2015)
10.1002/hep.26573
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
Chuan Yin (2013)
10.7497/j.issn.2095-3941.2013.04.003
Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks
G. G. Gomez (2013)
10.1038/nrc3559
Targeting the ERBB family in cancer: couples therapy
Niall C. Tebbutt (2013)
MiR134/487b/655 cluster regulates TGF-betainduced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells
K Kitamura (2014)
2016 The Authors
1982 ª 2016 The Authors
10.3322/caac.21149
Cancer treatment and survivorship statistics, 2012.
Rebecca L Siegel (2012)
Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage.
C. Kari (2003)
10.1007/s11626-012-9482-3
MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation
Xiaoying Zhang (2012)
10.1200/JCO.2010.28.6260
Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations.
Kuei-Pin Chung (2010)
10.1158/1535-7163.MCT-13-0448
MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
Kazuhiro Kitamura (2013)
10.1038/nrc2867
Genetic variation in microRNA networks: the implications for cancer research
Bríd M. Ryan (2010)
10.1016/j.bbrc.2015.07.021
MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway.
Tianjun Chen (2015)
10.1016/j.addr.2014.05.009
In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
Yunching Chen (2015)
Target - ing the ERBB family in cancer : couples ther
M Ha (2013)
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting micro- RNAs for cancer therapy
Al Kasinski (2011)
10.1158/1078-0432.CCR-09-1736
MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
M. Landi (2010)
10.1200/JCO.2009.24.0747
Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations.
Chun-Nin Lee (2010)
10.1371/journal.pone.0096765
MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma
Lu-kai Wang (2014)
10.1073/pnas.80.5.1337
Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.
T. Kawamoto (1983)
10.1038/nature07299
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Y. Tay (2008)
10.1126/science.1099314
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Paez (2004)



This paper is referenced by
10.1038/oncsis.2017.50
MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis
Y. Li (2017)
microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).
Y. Li (2018)
10.1002/prp2.528
MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential
Hannah Petrek (2019)
10.18632/oncotarget.16854
Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer
X. Liu (2017)
10.7150/ijbs.22243
MicroRNAs associated with therapy of non-small cell lung cancer
Junmi Lu (2018)
10.1021/acsnano.7b04878
The Exosome Total Isolation Chip.
Fei Liu (2017)
10.3892/or.2017.5619
miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1
Zaiting Ye (2017)
10.4149/neo_2017_406
miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1.
Xing Wu Hou (2017)
10.1139/bcb-2018-0211
MicroRNA-134 Deactivates Hepatic Stellate Cells by Targeting TGF-β Activated Kinase 1-Binding Protein 1.
P. Wang (2019)
10.1016/j.biopha.2016.12.007
miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer.
Tianjun Chen (2017)
10.4103/jcrt.JCRT_208_18
Multiple MicroRNAs synergistically promote tolerance to epidermal growth factor receptor-targeted drugs in smoked lung cancer therapies
L. Pan (2019)
10.3892/or.2017.5350
miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
Qin Qin (2017)
10.1038/s41388-018-0576-6
The risk variant rs884225 within EGFR impairs miR-103a-3p’s anti-tumourigenic function in non-small cell lung cancer
Zhongyi Fan (2018)
10.1093/carcin/bgy022
MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS
Zhi-Liang Wang (2018)
10.1016/j.cca.2020.01.034
MicroRNAs in Venous Thrombo-Embolism.
Anju Angelina Hembrom (2020)
10.1002/ijc.31638
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Shih-Yuan Peng (2018)
10.1016/j.bbrc.2017.07.093
Long non-coding RNA PCAT7 regulates ELF2 signaling through inhibition of miR-134-5p in nasopharyngeal carcinoma.
Yejun Liu (2017)
10.1038/s41598-020-61688-7
Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation
Sofía del Carmen (2020)
10.1080/17476348.2017.1355241
DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer
Jhon R. Enterina (2017)
10.1002/jcb.28003
Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134.
Yonggang Li (2018)
10.1016/j.ebiom.2019.07.050
MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway
Wei-wei Wang (2019)
10.1007/s12031-018-1118-y
The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA)
Ali Zekri (2018)
10.1016/j.omtn.2019.09.025
miR-134-5p Promotes Stage I Lung Adenocarcinoma Metastasis and Chemoresistance by Targeting DAB2
Liang Zhang (2019)
10.1111/jphp.13188
CircZNF609/miR-134-5p/BTG-2 axis regulates proliferation and migration of glioma cell.
Hui Tong (2019)
10.1117/1.JBO.22.9.096010
Facilitating in vivo tumor localization by principal component analysis based on dynamic fluorescence molecular imaging
Yang Gao (2017)
10.3390/ijms20071611
The Roles of MicroRNA in Lung Cancer
Kuan-Li Wu (2019)
10.1111/febs.14132
hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma
X. Zhu (2017)
10.1016/j.omtn.2016.11.003
miR-134: A Human Cancer Suppressor?
Jingyu Pan (2017)
10.1002/jcb.29295
Tumor suppressor microRNAs in lung cancer: An insight to signaling pathways and drug resistance.
Vahid Asghariazar (2019)
10.2174/1381612823666170714150118
Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies.
Xiaohong Du (2018)
10.1016/j.biopha.2019.108814
lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.
Fuquan Jiang (2019)
10.18632/oncotarget.25965
Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells
Svenja Groeneveld (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar